When the deal was done 120mil shares were worth $600,000. Try not to be too selective in your quotes. If you don't like it don't buy it, or buy it and ramp it.Regards
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%